Sign In
Buy UBS
$52.84
-0.730 (-1.36%)
At Close: Aug 06, 2026
UBS beats expectations as third-quarter profit soars to $2.5 billion
01:57am, Wednesday, 29'th Oct 2025
UBS said third-quarter net profit surged 74% to $2.5 billion, handily beating expectations as revenues climbed amid financial market volatility caused by global tariff turmoil.
UBS posts third quarter net profit of $2.48 bln
01:50am, Wednesday, 29'th Oct 2025
UBS Group on Wednesday reported a net profit attributable to shareholders of $2.48 billion in the third quarter, beating an average analysts' estimate of $1.29 billion, according to a company-provided
UBS posts 74% jump in third-quarter profit, beating expectations
01:49am, Wednesday, 29'th Oct 2025
Swiss banking giant UBS on Wednesday reported stronger-than-expected third-quarter net profit, citing significant momentum in its core businesses.
ZURICH--(BUSINESS WIRE)--Regulatory News: UBS (NYSE:UBS) (SWX:UBSN): “We delivered an excellent 3Q25 financial performance powered by significant momentum in our core businesses and disciplined exec
LifeStance to Present at the UBS Global Healthcare Conference
04:10pm, Tuesday, 28'th Oct 2025
SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that manageme
Tom Hayes, Face of Libor Scandal, Sues UBS for $400 Million
05:04pm, Monday, 27'th Oct 2025
The former banker spent five years in prison for his involvement in the manipulation of the benchmark rate.
UBS Welcomes Financial Advisor Bryan Davidson in Scottsdale, Arizona
12:30pm, Monday, 27'th Oct 2025
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- #FA--UBS Global Wealth Management today announces that Bryan Davidson has joined the firm as a Financial Advisor in the UBS Scottsdale, Arizona office.
UBS files application for US banking licence
10:32am, Monday, 27'th Oct 2025
UBS has filed an application for a national banking licence in the United States, the Swiss bank said on Monday, a step that underlines its growth ambition for the U.S. market.
Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference
08:00am, Monday, 27'th Oct 2025
MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima
UBS Group AG $UBS Stock Holdings Reduced by Allspring Global Investments Holdings LLC
03:46am, Friday, 24'th Oct 2025
Allspring Global Investments Holdings LLC lowered its position in UBS Group AG (NYSE: UBS) by 52.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exch
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
04:30pm, Wednesday, 22'nd Oct 2025
WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial O
Italian Investment Manager Adds More Shares of Global Financial Titan. Should Retail Investors Follow Suit?
12:04pm, Wednesday, 22'nd Oct 2025
Increased UBS position by 380,665 shares; estimated trade value of $14,783,661 for the quarter ended September 30, 2025, based on the average quarterly price Post-trade stake totals 2,337,752 shares,
UBS (UBS) Reports Next Week: Wall Street Expects Earnings Growth
11:07am, Wednesday, 22'nd Oct 2025
UBS (UBS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Down 10.7% in 4 Weeks, Here's Why You Should You Buy the Dip in UBS (UBS)
10:35am, Wednesday, 22'nd Oct 2025
UBS (UBS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnin
Sunrun (NASDAQ:RUN) Shares Gap Up Following Analyst Upgrade
01:36am, Wednesday, 22'nd Oct 2025
Shares of Sunrun Inc. (NASDAQ: RUN - Get Free Report) gapped up prior to trading on Tuesday after UBS Group raised their price target on the stock from $16.00 to $26.00. The stock had previously close
